Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis (PROVE)

Pfizer

Status: Completed

Conditions: Arthritis, Psoriatic

Treatments: Other: Questionnaire

Study type: Observational

Funder types: Industry

Identifiers

NCT00938015

B1801107

0881A-101698

Details and patient eligibility

About

The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteria.

Enrollment: 303 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Active erosive psoriatic arthritis of poly-articular type or active erosive or with joint space narrowing psoriatic arthritis of oligo-articular type
• At least 18 years old
• Have fulfilled reimbursement criteria for Enbrel in psoriatic arthritis of poly-articular type or oligo-articular type
• Physician decides to prescribe Enbrel or patient is already on Enbrel
• Give written informed consent at time of inclusion to study

Exclusion criteria

NA

Trial design

303 participants in 2 patient groups

PsA Patients (New)

Description:

New patients

Treatment:

Other: Questionnaire

Other: Questionnaire

PsA Patients

Description:

CU patients

Treatment:

Other: Questionnaire

Other: Questionnaire